| A Trial to Understand How Safe and Well Tolerated ZP9830 is and How it Works in People With Plaque Psoriasis Over an 8-week Treatment Period (NCT07733089) | Zealand Pharma | 2026-07-22 |
| A Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP6590 in Participants With Normal Weight, Overweight and Obesity (NCT07721597) | Zealand Pharma | 2026-07-09 |
| Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic Function (NCT07682818) | Zealand Pharma | 2026-05-18 |
| Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS (NCT07197944) | Zealand Pharma | 2026-02-11 |
| Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product Concentrations (NCT07338214) | Zealand Pharma | 2025-12-17 |
| Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (NCT07228403) | Zealand Pharma | 2025-12-11 |
| Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2) (NCT06926842) | Zealand Pharma | 2025-04-22 |
| Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function (NCT07076030) | Zealand Pharma | 2025-04-15 |
| A Trial Comparing Pharmacokinetics, Safety and Tolerability of Two Subcutaneous Concentrations of Dapiglutide (NCT06758583) | Zealand Pharma | 2024-12-23 |
| Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities (NCT06662539) | Zealand Pharma | 2024-12-09 |
| A Research Study Looking at the Safety of Single and Multiple Doses of ZP9830 and How it Works in the Body of Healthy Participants (NCT06682975) | Zealand Pharma | 2024-11-12 |
| A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570 (NCT06000891) | Zealand Pharma | 2023-09-15 |
| A Study to Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With T1D (NCT05378672) | Zealand Pharma | 2023-05-09 |
| Efficacy and Safety of Dasiglucagon for Treatment of Post-bariatric Hypoglycemia in Roux-en-Y Gastric Bypass (RYGB) Operated Adults (NCT04824872) | Zealand Pharma | 2023-02-01 |
| A Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy Participants (NCT05613387) | Zealand Pharma | 2022-11-07 |
| A First-in-human Study Looking at the Safety of ZP8396 and How it Works in the Body of Healthy Trial Participants (NCT05096598) | Zealand Pharma | 2021-10-19 |
| The Long-term Effect on Intestinal Absorption and Safety of Treatment With Glepaglutide in Patients With Short Bowel Syndrome (NCT04991311) | Zealand Pharma | 2021-08-10 |
| Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial (NCT04881825) | Zealand Pharma | 2021-06-16 |
| A Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570 (NCT04612517) | Zealand Pharma | 2020-10-26 |
| Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism (NCT04172441) | Zealand Pharma | 2020-06-19 |
| A Bridging Trial to Compare the PK Profile When Glepaglutide is Administered Via Vial/Syringe Versus Autoinjector. (NCT04318743) | Zealand Pharma | 2020-03-04 |
| Pharmacokinetic Profile of Glepaglutide After a Single Injection in Subjects With Varying Degrees of Renal Function (NCT04178447) | Zealand Pharma | 2019-12-10 |
| A Single Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570 (NCT03994549) | Zealand Pharma | 2019-06-14 |
| Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS (NCT03905707) | Zealand Pharma | 2019-05-07 |
| Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism (NCT03941236) | Zealand Pharma | 2019-05-02 |
| A Trial to Compare the Efficacy and Safety of 2 Different Batches of Subcutaneous Dasiglucagon in Patients With T1DM (NCT03895697) | Zealand Pharma | 2019-03-26 |
| A Two-Period Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism (NCT03777176) | Zealand Pharma | 2019-02-07 |
| Evaluation of the Safety, Tolerability and Bioavailability of Dasiglucagon Following Subcutaneous (SC) Compared to IV Administration (NCT03735225) | Zealand Pharma | 2018-11-07 |
| Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DM (NCT03688711) | Zealand Pharma | 2018-11-01 |
| Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS) (NCT03690206) | Zealand Pharma | 2018-10-04 |
| Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children (NCT03667053) | Zealand Pharma | 2018-09-28 |
| A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects (NCT03378635) | Zealand Pharma | 2017-12-07 |
| Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects (NCT03279302) | Zealand Pharma | 2017-09-04 |